FDA Greenlights Vanda Pharmaceuticals’ Bipolar Disorder Drug: Fanapt Approved for Manic Episodes

FDA Greenlights Vanda Pharmaceuticals’ Bipolar Disorder Drug: Fanapt Approved for Manic Episodes

Vanda Pharmaceuticals Inc. celebrated a significant milestone as the U.S. Food and Drug Administration (FDA) granted approval for its groundbreaking…

Read More »